Quantum Financial Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$255K Buy
1,616
+48
+3% +$7.58K 0.13% 131
2026
Q2
$248K Buy
+1,568
New +$212K 0.13% 129

Other funds holding XBI

Quantum Financial Partners's XBI Position: Q3 2026 in Review

Quantum Financial Partners increased its State Street SPDR S&P Biotech ETF (XBI) stake by 3.1% in Q3 2026, buying an estimated $7.58K and bringing the position to 1,616 shares worth $255K. The position accounts for 0.13% of the portfolio, ranked #131.

Quantum Financial Partners first reported a position in XBI in Q2 2026 and has held it in 2 quarters since. 734 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Quantum Financial Partners held 1,616 shares of State Street SPDR S&P Biotech ETF worth $255K as of Q3 2026.
  • Quantum Financial Partners bought 48 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $7.58K.
  • State Street SPDR S&P Biotech ETF made up 0.13% of Quantum Financial Partners's portfolio in Q3 2026, its #131 holding.
  • Quantum Financial Partners first reported a position in State Street SPDR S&P Biotech ETF in Q2 2026 and has held it in 2 quarters since.
  • 734 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Quantum Financial Partners's 13F filing for Q3 2026, filed 19 Oct 2026.